Total Funding
21
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Neograft Technologies focuses on developing cardiac technologies for use the heart bypass procedures.
Richard C. Petersen: ChairmanPast Role: Aptiv, General Director of Corporate Planning for Delphi-Steering- David Wagner: Team MemberPast Role: HuzuTech, Senior Software Engineer
About the Company
Neograft Technologies focuses on developing cardiac technologies for use in heart bypass procedures. The company's products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts.
It was founded in 2009 and headquartered in Taunton, Massachusetts.
